Appco Pharma LLC 2026-04-08 Health serious FDA
Health · FDA · Recall #FDA-D-0420-2026
Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for:… Recall
Issued April 8, 2026 · Appco Pharma LLC
In April 2026, Appco Pharma LLC recalled the Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for:…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
What you should do
- 1 Stop using Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Appco Pharma LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Appco Pharma LLC
- Category
- Health
- Recall date
- April 8, 2026
- Units affected
- Not reported
- Sold at
- U.S.A. Nationwide
- Recall number
- FDA-D-0420-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Appco Pharma LLC has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.